Aug 09, 2024 Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Jun 20, 2024 Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
May 16, 2024 Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
May 15, 2024 Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Mar 18, 2024 Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
